Jiang Panfeng ’26Computer Science and Technology, School of Information Science and Technology (SIST)High School: Wenling High School, Zhejiang ProvinceHonors and awards-ShanghaiTech Outstanding Student (November 2025)-Champion, Bay Area Decision Science Summit 2025 (March 2025)-International Finalist (Top 0.1%) and AMS Award, Mathematical Contest in Modeling (MCM/ICM) (January 2025)-Third P...

Last week, Frank Wise, the Samuel B. Eckert Professor at Cornell University and a Fellow of both the Optical Society (Optica) and the American Physical Society, delivered a lecture at the ShanghaiTech Lecture Series. Titled “New Fiber Sources of Femtosecond Pulses,” the talk offered both cutting-edge insights and academic depth. The event was chaired by Xie Xiaoming, dean of the School of Physic...

On March 25, the Shanghai Clinical Research and Trial Center (the Center) and Cytiva officially signed a strategic cooperation agreement. The two parties will engage in deep collaboration in the cutting-edge fields of cell and gene therapy, jointly establishing an Advanced Cell Therapy Technology Clinical Application Demonstration Platform. The initiative aims to bridge the entire chain from basic...

Liu Qizhen is a Class of 2026 undergraduate at the School of Life Science and Technology (SLST), majoring in Biological Sciences with a minor in Finance. He has been honored as a ShanghaiTech Outstanding Student for three consecutive years.Honors & Awards:Ÿ- iGEM Gold Medal (2023–2025)- SynBio Challenges 2024 Gold Medal- SynBio Challenges 2025 Silver Medal- ShanghaiTech Outstanding Studen...

On March 16, a delegation representing the global biopharmaceutical giant AstraZeneca, alongside scholars from King’s College London (KCL), the University of Glasgow, and the University of Oxford, visited the School of Life Science and Technology (SLST) at ShanghaiTech University. The visit aimed to deepen the China-UK dialogue in frontier biomedical fields, explore collaborative models for indus...

Wang Yiru, born in 2000 in Xinxiang City, Henan Province, is a 2024 PhD student trained jointly at the School of Life Science and Technology (SLST) and the Shanghai Institute for Advanced Immunochemical Studies (SIAIS). During her doctoral studies, she published research papers as co-first author in top international journals including Cell, Science Advances, and Nature Communications. A...

Following myocardial infarction, the heart undergoes adverse remodeling driven by inflammation, cell necrosis, and fibrotic scar formation, ultimately leading to heart failure. However, the cellular and molecular mechanisms driving this process have not been fully elucidated. Recently, a research team led by Associate Professor Zhang Hui of the School of Life Science and Technology (SLST...

Profile of Xu Zhengde2023 doctoral student in Electronic Science and Technology, School of Information Science and Technology (SIST)Supervisor: Assistant Professor Zhu Zhifeng Research achievements: Ÿ -Published a total of 12 papers in internationally authoritative SCI journals, including seven papers as first author or co-first author in journals such as Phys. Rev. Lett., Phys. Rev...

Profile of Su Mengjiao ’21 Su is a 2021 graduate student in Chemistry at the School of Physical Science and Technology (SPST), under the supervision of Professor Ji Quanjiang. She focuses on the development of CRISPR-Cas system gene-editing tools and the research of their molecular mechanisms. Her work has been published in top international journals such as Nature Chemical Biology and ...

Our body has special immune cells called T cells that fight tumors. On the surface of T cells is a protein called TCR, which recognizes a small special marker (antigen) on the surface of tumor cells. Once it detects the marker, the T cell launches an attack to eliminate the tumor.However, many tumors escape detection by altering, reducing, or completely removing this marker, making it hard for T c...

Metabolic dysfunction-associated steatotic liver disease/steatohepatitis (MASLD/MASH) has become the most common chronic liver disease worldwide. Due to increasing obesity and metabolic problems, more than 30% of people globally have varying degrees of fatty liver disease. Current approved drugs mainly include resmetirom and semaglutide, but these are limited in number, expensive, and have restric...

On February 19, a breakthrough study was published online in Nature in a paper titled “Integrated photonics enabling ultra-wideband fiber–wireless communication.” This work was jointly completed by Associate Professor Chen Baile from the School of Information Science and Technology (SIST) at ShanghaiTech, Professor Wang Xingjun and Assistant Professor Shu Haowen at Peking University, a...

On February 11, a research team led by Ge Jingpeng from the School of Life Science and Technology (SLST) at ShanghaiTech University and Yu Jie from the Interdisciplinary Research Center on Biology and Chemistry (IRCBC) at the Shanghai Institute of Organic Chemistry published a study in Nature entitled “Conformational diversity and fully opening mechanism of native NMDA receptor.” ...

Targeted protein degradation (TPD) approaches represent a breakthrough in drug development. Unlike traditional occupancy-driven inhibitors, TPD exploits the ubiquitin-proteasome system (UPS) to eliminate disease-causing proteins that were previously considered “undruggable.” Currently, several TPD drugs have shown clinical potential in treating many diseases. However, with extended treatment, pa...